Tag: iShares U.S. Healthcare ETF

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Here’s Jim Cramer’s advice for navigating the markets during the Iran conflict

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen